A detailed history of Frazier Financial Advisors, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 251 shares of INVA stock, worth $4,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares
251
Previous 1,069 76.52%
Holding current value
$4,999
Previous $17.5 Million 72.35%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$16.33 - $20.04 $13,357 - $16,392
-818 Reduced 76.52%
251 $4.85 Million
Q2 2024

Aug 12, 2024

BUY
$14.4 - $16.4 $13,060 - $14,874
907 Added 559.88%
1,069 $17.5 Million
Q1 2024

May 13, 2024

BUY
$14.56 - $16.78 $2,358 - $2,718
162 New
162 $2.47 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.39B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.